1090P High concurrent interferon gamma signature expression in the primary tumor and lymph node metastasis is associated with superior outcome upon neoadjuvant ipilimumab + nivolumab in stage III melanoma
Lianne Hoeijmakers, Petros Dimitriadis, Sten Cornelissen, Irene L. M. Reijers, B. van de Wiel, Richard A Scolyer, R.P.M. Saw, Andrew J. Spillane, A. Broeks, Marta López‐Yurda, L. Grijpink-Ongering, G. Hospers, Alexander M. Menzies, Alexander C.J. van Akkooi, W. Van Houdt, G.V. Long, Christian U. Blank (2024). 1090P High concurrent interferon gamma signature expression in the primary tumor and lymph node metastasis is associated with superior outcome upon neoadjuvant ipilimumab + nivolumab in stage III melanoma. , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.1158.
